Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment

Area of Science:

• Endocrinology
• Oxidative Stress Research
• Biochemistry

Background:

• Thyroid hormones significantly influence cellular metabolism and oxidative processes.
• Hyperthyroidism is associated with increased metabolic rate, potentially leading to oxidative stress.
• Lipid peroxidation is a marker of oxidative damage and cellular dysfunction.

Purpose of the Study:

• To investigate lipid peroxidation levels and cellular antioxidant capacity in hyperthyroid and hypothyroid patients.
• To evaluate the effect of propylthiouracil (PTU) treatment on these parameters in hyperthyroidism.
• To explore the relationship between thyroid status, oxidative stress, and cellular function.

Main Methods:

• Measurement of plasma and urinary thiobarbituric acid reactive substances (TBAR) as lipid peroxidation markers.
• Assessment of erythrocyte functional tests including t-butyl hydroperoxide (t-BHP)-induced oxygen uptake and chemiluminescence.
• Comparison of parameters in hyperthyroid patients, hypothyroid patients, and controls, with follow-up after PTU treatment.

Main Results:

• Hyperthyroid patients showed significantly higher plasma and urinary TBAR levels compared to controls.
• Erythrocytes from hyperthyroid patients exhibited increased oxygen consumption, enhanced chemiluminescence, and shorter induction periods.
• PTU treatment reduced TBAR levels and normalized erythrocyte functional tests in hyperthyroid patients.
• Hypothyroid patients displayed no significant changes, except for diminished t-BHP-induced chemiluminescence.

Conclusions:

• Hyperthyroidism is characterized by a pro-oxidant state with increased lipid peroxidation.
• PTU treatment effectively suppresses oxidative stress markers in hyperthyroidism.
• Cellular oxidative stress may occur in thyroid hormone target tissues, contributing to hyperthyroid symptoms.